Increasing protein intake with whole foods for cancer patients after treatment
Can Protein Intake be Increased Using Whole Foods Post-treatment in Cancer Patients?
This study tests if eating more eggs can help cancer patients who have finished chemotherapy feel better and recover faster.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Alberta Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Edmonton, Alberta) |
| Trial ID | NCT05859100 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates whether increasing protein intake through the consumption of eggs can help restore nutritional status and improve immune function and quality of life in cancer patients who have completed platinum chemotherapy. The study involves an 8-week randomized design where participants are divided into two groups: one receiving the nutritional intervention of at least two eggs daily and the other following their usual diet for the first four weeks. The trial aims to assess the impact of this dietary change on muscle mass and overall recovery post-treatment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have histopathologically confirmed cancer and have recently completed platinum chemotherapy.
Not a fit: Patients with a known allergy to eggs or those who are unable to consume food orally will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance recovery and quality of life for cancer patients post-treatment by improving their nutritional status.
How similar studies have performed: While the specific approach of using eggs as a protein source in this context may be novel, similar nutritional interventions have shown promise in improving recovery outcomes in cancer patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients must have the ability to read, understand, and sign an informed consent and must be willing to comply with study treatment and follow-up. * ≥18 years of age * Histopathologically confirmed cancer with receipt of a platinum chemotherapy during treatment; active treatment has concluded. * Capable of volitional oral semi-solid intake at baseline; able to maintain oral intake over the trial. Exclusion Criteria: * Fed by nasogastric tube, gastrostomy, or total parenteral nutrition * Cancer of the brain, Cancer of the regions which impact an individual's ability to consume food. * A known hypersensitivity / allergy to eggs. * Enrolment in any other clinical protocol or investigational study that may interfere with study procedures. * Poorly controlled chronic illnesses or other inflammatory diseases (e.g. Chronic Obstructive Pulmonary Disease(COPD), uncontrolled non-insulin dependent diabetes, rheumatoid arthritis). * In a clinician opinion, patients who have medical conditions that could interfere with nutrient metabolism or absorption (e.g., short bowel syndrome, Crohn's disease, etc.)
Where this trial is running
Edmonton, Alberta
- University of Alberta — Edmonton, Alberta, Canada (Recruiting)
Study contacts
- Principal investigator: Vera Mazurak, PhD — University of Alberta
- Study coordinator: Vera Mazurak, PhD
- Email: vmazurak@ualberta.ca
- Phone: 780-492-8048
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.